Teva Pharmaceuticals to lay off 14,000 employees worldwide, 1,750 in Israel - The Jerusalem Post
Teva to pay up to $4.2 billion in U.S. to settle opioid claims | Reuters
CSRWire - Teva Highlights Key Milestones Achieved in the 2017 Social Impact Report
Israel's ailing Teva to cut 25% of global workforce in recovery effort | The Times of Israel
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal
Teva looks to amp up research collaborations, CEO says
Teva Pharma Outplays Peers Despite Light Q3 Sales, Lacking 2017 Views | Stock News & Stock Market Analysis - IBD
Teva stock plummets 18% after rough quarter in US generic drug market
State of Virginia sues Teva Pharmaceuticals over opioids | AP News
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
Teva, still searching for 'world-class' CEO, officially puts women's health, cancer on the block | Fierce Pharma
Teva CEO Schultz likely won't renew employment contract: reports
Teva Shares in Double-digit Free Fall in N.Y. and Tel Aviv After Profit Forecast Slashed - Business - Haaretz.com
Teva Names Interim CEO, New Chairman As Vigodman Steps Down
Teva Pharmaceuticals to Lay Off 14,000 People
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva is primed for a big bounce after years of underperformance, Barclays says
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva's new plan is to raise drug prices, but it won't be easy - MarketWatch
Stark Wipes Out $235M Infringement Verdict Against Teva for Hypertension Drug | Delaware Business Court Insider
Teva Faces Rocky Path to Recovery After Debt | Fortune
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
Israel-based Teva settles opioid lawsuit with San Francisco for $45M – J.
